Earlier puberty as a predictor of later onset of schizophrenia in women

American Journal of Psychiatry

Volumn 156, Issue 7, 1999, Pages 1059-1064

  Cohen, Robin Z ^a   Seeman, Mary V ^a,b   Gotowiec, Andrew ^a   Kopala, Lili ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BIRTH INJURY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENDER; HEAD INJURY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENARCHE; PRIORITY JOURNAL; PUBERTY; SCHIZOIDISM; SCHIZOPHRENIA; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; AGE OF ONSET; FAMILY; FEMALE; HOSPITALIZATION; HUMANS; MALE; MENARCHE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX FACTORS;

EID: 0033008035     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Castle DJ, Abel K, Takei N, Murray RM: Gender differences in schizophrenia: hormonal effects or subtypes? Schizophr Bull 1995; 21:1-12
2. Castle DJ, Murray RM: The epidemiology of late-onset schizophrenia. Schizophr Bull 1993; 19:691-700
3. Häfner H, Riecher-Rössler A, an der Heiden W, Maurer K, Fatkenheuer B, Löffler W: Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 1993; 23:925-940
4. Sartorius N, Jablensky A, Korten A, Ernberg G, Anker M, Cooper JE, Day R: Early manifestations and first contact incidence of schizophrenia in different cultures: a preliminary report on the initial evaluation phase of the WHO collaborative study on determinants of outcome of severe mental disorders. Psychol Med 1986; 16:909-928
5. Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA: Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor mediated synaptic input: correction with dendritic spine density. J Neurosci 1997; 17: 1848-1859
6. Woolley CS, McEwen BS: Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 1992; 12:2549-2554
7. Smith SS: Female sex steroid hormones: from receptors to networks to performance - actions on the sensorimotor system. Prog Neurobiol 1994; 44:55-86
8. Birge SJ: The role of estrogen in the treatment of Alzheimer's disease. Neurology 1997; 48(suppl 7):S36-S41
9. Xu H, Gouras GK, Greenfield JP, Vincent B, Naslund J, Mazzarelli L, Fried G, Jovanovic JN, Seeger M, Relkin NR, Liao F, Checler F, Buxbaum JD, Chait BT, Thinakaran G, Sisodia SS, Wang R, Greengard P, Gandy S: Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med 1998; 4:447-451
10. Toran-Allerand CD: The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant? Dev Neurosci 1996; 18:36-48
11. Häfner H, Behrens S, De Vry J, Gattaz WF: Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Eur Arch Psychiatr Clin Neurosci 1991; 241:65-68
12. Hallonquist JD, Seeman MV, Lang M, Rector NA: Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry 1993; 33:207-209
13. Gattaz WF, Vogel P, Riecher-Rössler A, Soddu G: Influence of the menstrual cycle phase on the therapeutic response in schizophrenia. Biol Psychiatry 1994; 35:137-139
14. Seeman MV: The role of estrogen in schizophrenia. J Psychiatry Neurosci 1996; 21:123-127
15. Fink G, Sumner BEH, Rosie R, Grace O, Quinn JP: Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 1996; 16: 325-344
16. DeQuardo JR, Carpenter CF, Tandon R: Patterns of substance abuse in schizophrenia: nature and significance. J Psychiatr Res 1994; 28:267-275
17. Buckley P, Stack JP, Madigan C, O'Callaghan E, Larkin C, Redmond O, Ennis JT, Waddington JL: Magnetic resonance imaging of schizophrenia-like psychoses associated with cerebral trauma: clinicopathological correlates. Am J Psychiatry 1993; 150:146-148
18. Verdoux H, Geddes JR, Takei N, Lawrie SM, Bovet P, Eagles JM, Heun R, McCreadie RG, McNeil TF, O'Callaghan E, Stöber G, Willinger U, Wright P, Murray RM: Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. Am J Psychiatry 1997; 154:1220-1227
19. DeLisi LE, Bass N, Boccio A, Shields G, Morgenti C: Age of onset in familial schizophrenia. Arch Gen Psychiatry 1994; 51: 334-335
20. Cohen J: Statistical Power Analyses for the Behavioral Sciences, 2nd ed. Hillsdale, NJ, Lawrence Erlbaum Associates, 1988
21. First MB, Williams JBW, Spitzer RL: DTREE for Windows: The DSM-IV Expert. North Tonawanda, NY, Multi Health Systems, 1997
22. First MB, Opler LA, Hamilton RM, Linder J, Linfield LS, Silver JM, Toshav NL, Kahn D, Williams JBW, Spitzer RL: Evaluation in an inpatient setting of DTREE, a computer-assisted diagnostic assessment procedure. Compr Psychiatry 1993; 34: 171-175
23. Häfner H, Riecher-Rössler A, Fatkenheuer B, Maurer K, Meissner S, Löffler W, Patton G: Interview for the Retrospective Assessment of the Onset of Schizophrenia (IRAOS). Schizophr Res 1992; 6:209-223
24. Maurer K, Häfner H: Methodological aspects of onset assessment in schizophrenia. Schizophr Res 1995; 15:265-276
25. Gilger JW, Geary DC, Eisele LM: Reliability and validity of retrospective self reports of the age of pubertal onset using twin, sibling, and college student data. Adolescence 1991; 26:41-53
26. Casey VA, Dwyer JT, Coleman KA, Krall EA, Gardner J, Valadian I: Accuracy of recall by middle-aged participants in a longitudinal study of their body size and indices of maturation earlier in life. Ann Hum Biol 1991; 18:155-166
27. Koo MM, Rohan TE: Accuracy of short-term recall of age at menarche. Ann Hum Biol 1997; 24:61-64
28. Hambrecht M, Häfner H: Sensitivity and specificity of relatives' reports on the early course of schizophrenia. Psychopathology 1997; 30:12-19
29. Endicott J, Andreasen N, Spitzer RL: Family History Research Diagnostic Criteria, 3rd ed. New York, New York State Psychiatric Institute, Biometrics Research, 1978
30. Andreasen NC, Grove WM, Shapiro RW, Keller MB, Hirschfeld RM, McDonald-Scott P: Reliability of lifetime diagnosis: a multicenter collaborative perspective. Arch Gen Psychiatry 1981; 38:400-405
31. Lewis SW, Owen MJ, Murray RM: Obstetric complications and schizophrenia: methodology and mechanisms, in Schizophrenia: Scientific Progress. Edited by Schulz SC, Tamminga CA. New York, Oxford University Press, 1989, pp 56-68
32. Arimatsu Y, Hatanaka H: Estrogen treatment enhances survival of cultured fetal rat amygdala neurons in a defined medium. Brain Res Dev Brain Res 1986; 26:151-159
33. Shugrue PJ, Dorsa DM: Gonadal steroids modulate the growth-associated protein GAP-43 (neuromodulin) mRNA in postnatal rat brain. Brain Res Dev Brain Res 1993; 73:123-132
34. Sohrabji F, Miranda RC, Toran-Allerand CD: Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci 1994; 14:459-471
35. Kendall RE, Chalmers JC, Platz C: Epidemiology of puerperal psychoses. Br J Psychiatry 1987; 150:662-673
36. Riecher-Rössler A, Häfner H, Stumbaum M, Maurer K, Schmidt R: Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 1994; 20:203-214
37. Seeman MV: Psychopathology in women and men: focus on female hormones. Am J Psychiatry 1997; 154:1641-1647